Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease.
about
Mitochondria-associated ER membranes and Alzheimer diseaseBiological relevance of fatty acyl heterogeneity to the neural membrane dynamics of Rhesus macaques during normative agingLipid-binding properties of human ApoD and Lazarillo-related lipocalins: functional implications for cell differentiation.Regional changes in CNS and retinal glycerophospholipid profiles with age: a molecular blueprintDeficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer's DiseaseAge and haplotype variations within FADS1 interact and associate with alterations in fatty acid composition in human male cortical brain tissueMitofusin-2 knockdown increases ER-mitochondria contact and decreases amyloid β-peptide productionAn amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease.Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.Age-related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: a spontaneous Alzheimer's disease mouse model.Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchPlasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.A Signaling Lipid Associated with Alzheimer's Disease Promotes Mitochondrial DysfunctionWide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MSStreptozotocin-induced diabetes partially attenuates the effects of a high-fat diet on liver and brain fatty acid composition in mice.Fatting the brain: a brief of recent researchLipotoxicity of palmitic Acid on neural progenitor cells and hippocampal neurogenesis.Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline.Lipidomics of Alzheimer's disease.Lipid metabolism in Alzheimer's diseaseTibolone Preserves Mitochondrial Functionality and Cell Morphology in Astrocytic Cells Treated with Palmitic Acid.Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.Palmitic acid-induced neuron cell cycle G2/M arrest and endoplasmic reticular stress through protein palmitoylation in SH-SY5Y human neuroblastoma cells.On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis.Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analysesAlzheimer Classification Using a Minimum Spanning Tree of High-Order Functional Network on fMRI Dataset.Sex differences in the phagocytic and migratory activity of microglia and their impairment by palmitic acid.The effect of fish oil supplementation on brain DHA and EPA content and fatty acid profile in mice.Decreased liver peroxisomal β-oxidation accompanied by changes in brain fatty acid composition in aged rats.Neural stem cells and adult brain fatty acid metabolism: Lessons from the 3xTg model of Alzheimer's disease.DHA supplementation enhances high-frequency, stimulation-induced synaptic transmission in mouse hippocampus.Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease.Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.Palmitic acid induces neurotoxicity and gliatoxicity in SH-SY5Y human neuroblastoma and T98G human glioblastoma cells.Using direct infusion mass spectrometry for serum metabolomics in Alzheimer's disease.
P2860
Q26745495-6DBA46B9-50F7-42DD-9A3B-52CD998644C2Q29248873-45FF010E-5018-4346-AE29-CCF4462B559CQ30155078-D43D37A4-E815-40BA-9285-DEC786DE8BC4Q33567994-8B7C19B4-E802-486B-8886-25F6FF695B3AQ33691534-D501F3F8-E246-49CF-8379-8B436C5EDDA6Q33844975-1BB5369D-4806-42C4-96C2-F98F278DD9A1Q34382545-1D18A5D4-B3DF-4FC6-8271-C8D62791099FQ34527610-209788E2-C7D0-46E9-BEE0-BD72F7B2095BQ35159081-D06434FB-1214-45AB-B223-549231E72C0DQ35179546-FD7BEEA2-634A-4572-B178-27B55D9DF8FEQ35218379-A2D7D2DC-5573-4E83-BEC2-747BA6729C76Q35939827-36A160F7-3DCF-4561-BCCD-437EC5A299A9Q35993891-26533327-6BDA-4F03-8042-548B40438C4AQ36129673-5983CE3A-B5A3-4357-A7DA-180305655A7CQ36132033-A2F6BA11-A175-4F05-AF20-F503C067FDF5Q36457368-3F1194C5-52E0-4536-BE95-A8DDDE5D35A9Q36499256-D7BF27F1-129B-4408-884B-52A122790F58Q36595126-336518CC-AC09-4199-8F22-74D3F7BFAE50Q37140449-99C32BD8-D6F5-4F2A-BBE4-45F23899D5C4Q37155461-59EBF9FC-5C16-4EE5-AA18-E70543DC717CQ37326225-DC73F02B-2E92-44FC-B823-ACB5CEADBD6AQ38150523-31FDA7FD-8DD2-4DCD-8254-A1252BB88AAEQ38191024-5ADF4B03-8AFF-4094-9C06-1484C2A41029Q38204719-42A2AFD0-86FE-4831-B303-619BCA36CF5CQ38699120-4F47A972-E352-46B3-8CBC-0270093981DFQ38926696-60A58727-251C-42F2-89D7-980E3F40911DQ38939976-F764658C-378B-4A3B-8C30-39644D599FD8Q39155255-B8E7B802-1422-452C-A931-EFDC279C9443Q42655692-18D60785-ABB4-4537-A1B4-DE1A80306F8EQ47132279-DAE4338E-F17E-4EA6-B54A-9F5282B79285Q47579436-6B871338-1CA6-4423-8CAC-4C94C3916A0EQ47909646-1EF0979B-E065-45C7-B5FD-0B4B4A700DD7Q47918258-7F4BC8FD-1EBC-457A-80D6-42574BE99B17Q48033206-555B0C08-E32F-4690-91F9-594BCA6BE54FQ48466461-48727285-E6BB-4215-8D41-68DCA09AF211Q48824358-ACE34768-5B7B-46AC-A479-7AA1CEB1B132Q51737097-8DF9BF1D-735B-4962-ACCF-534A3EB21166Q52373518-2662C825-0467-4446-AF12-91E19C7F78CDQ52715312-F0E3DE9F-369A-44BF-B5F9-8354695A70ADQ53356993-0C87A6C8-53F4-49B3-99FA-227C10E98F03
P2860
Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Fatty acid composition of fron ...... in and in Alzheimer's disease.
@en
Fatty acid composition of fron ...... in and in Alzheimer's disease.
@nl
type
label
Fatty acid composition of fron ...... in and in Alzheimer's disease.
@en
Fatty acid composition of fron ...... in and in Alzheimer's disease.
@nl
prefLabel
Fatty acid composition of fron ...... in and in Alzheimer's disease.
@en
Fatty acid composition of fron ...... in and in Alzheimer's disease.
@nl
P1476
Fatty acid composition of fron ...... in and in Alzheimer's disease.
@en
P2093
Thomas Fraser
P2888
P304
P356
10.1007/S11064-009-0087-5
P577
2009-11-11T00:00:00Z
P6179
1047307352